
Conference Coverage
27 days ago
AAOpt 2026: Equipping your amblyopia toolboxabout 1 month ago
AAOpt 2026: Managing complex pediatric myopia casesabout 1 month ago
AAOpt 2026: Patient-reported blurred vision improvement with VevyeLatest Content

2027 Medicare fee schedule trims same-day E/M, 0-day procedure pay

Hundred Vision's new eye-tracking system objectively assesses visual function

Indiana optometrists open state’s first OD-owned surgical suites

The Independent Advantage S02 E09: Where practices lose patients

Eyedaptic releases AI assistant Eva for patients with retinal disease

Shorts










Podcasts
Videos
Optometry Times Digital Edition





Continuing Medical Education
All News

Kansas, Tennessee, and Vermont expanded optometric scope in 2026, while vision plan reform and a proposed Medicare fee schedule cut affect practice management.

Bita Asghari, OD, FAAO, FSLS, discusses diagnosing ocular surface inflammation, recognizing atypical keratitis, and knowing when to refer to a cornea specialist.

The approval followed complete response letters tied to inspection and manufacturing issues.

What to take away on PBM, hormonal eye health, and GLP-1 receptor agonists from this year’s meeting.

Host Hamza Shah, OD, MS, FAAO, is joined by Melissa Barnett, OD, FAAO, FSLS, FBCLA, to discuss burnout among US optometrists, inspired by Abbott et al's nationwide survey.

From treating myopic complications to preventing them, eye care providers have ample opportunity to close a collaborative care gap.

This week’s top stories include pipeline updates in dry eye, retinitis pigmentosa, contact lens hygiene, and more.

The meeting, which comes a year after the agency issued a complete response letter in October 2025,2 was held from 8:30 am-3 pm ET and was open to public.

The licaminlimab trial enrolled 176 patients, two-thirds with a TNFR1 variant tied to stronger response. Data expected late 2026.

Nicole Haessly, OD, FAAO, discusses common unsafe contact lens habits, overlooked care steps, and how lens innovations have improved safety.

Amanda Nanasy, OD, discussed how sports can open the door to eye care for underserved athletes and what goes into her performance vision evaluations.

FDA grants orphan drug designation to oral OCT-980 for RHO-adRP, now in phase 1b/2 testing at US sites.

Raphael Rostenne discusses what a good phone call looks like and contributes to successful patient interactions with host Diana Canto-Sims, OD.

Amanda Nanasy, OD, described how her own concussion shaped her approach to athletes and why she ties every vision evaluation back to the demands of their sport.

Zachary Keaney, CPOA, discusses the lens care steps patients skip most often and why early diagnosis of lens-related keratitis is critical.







































